Cross-reactive antibodies against Langat virus protect mice from lethal tick-borne encephalitis virus infection.

Autor: Kubinski M; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany., Beicht J; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany., Zdora I; Department of Pathology, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany.; Center of Systems Neuroscience, Hannover Graduate School for Neurosciences, Infection Medicine, and Veterinary Sciences (HGNI), Hannover, Germany., Saletti G; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany., Kircher M; Institute for Animal Breeding and Genetics, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany., Petry-Gusmag M; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany., Steffen I; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany.; Institute for Biochemistry, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany., Puff C; Department of Pathology, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany., Jung K; Institute for Animal Breeding and Genetics, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany., Baumgärtner W; Department of Pathology, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany.; Center of Systems Neuroscience, Hannover Graduate School for Neurosciences, Infection Medicine, and Veterinary Sciences (HGNI), Hannover, Germany., Rimmelzwaan GF; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany., Osterhaus ADME; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany., Prajeeth CK; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany.
Jazyk: angličtina
Zdroj: Frontiers in immunology [Front Immunol] 2023 Feb 28; Vol. 14, pp. 1134371. Date of Electronic Publication: 2023 Feb 28 (Print Publication: 2023).
DOI: 10.3389/fimmu.2023.1134371
Abstrakt: Introduction: Naturally attenuated Langat virus (LGTV) and highly pathogenic tick-borne encephalitis virus (TBEV) share antigenically similar viral proteins and are grouped together in the same flavivirus serocomplex. In the early 1970s, this has encouraged the usage of LGTV as a potential live attenuated vaccine against tick-borne encephalitis (TBE) until cases of encephalitis were reported among vaccinees. Previously, we have shown in a mouse model that immunity induced against LGTV protects mice against lethal TBEV challenge infection. However, the immune correlates of this protection have not been studied.
Methods: We used the strategy of adoptive transfer of either serum or T cells from LGTV infected mice into naïve recipient mice and challenged them with lethal dose of TBEV.
Results: We show that mouse infection with LGTV induced both cross-reactive antibodies and T cells against TBEV. To identify correlates of protection, Monitoring the disease progression in these mice for 16 days post infection, showed that serum from LGTV infected mice efficiently protected from developing severe disease. On the other hand, adoptive transfer of T cells from LGTV infected mice failed to provide protection. Histopathological investigation of infected brains suggested a possible role of microglia and T cells in inflammatory processes within the brain.
Discussion: Our data provide key information regarding the immune correlates of protection induced by LGTV infection of mice which may help design better vaccines against TBEV.
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2023 Kubinski, Beicht, Zdora, Saletti, Kircher, Petry-Gusmag, Steffen, Puff, Jung, Baumgärtner, Rimmelzwaan, Osterhaus and Prajeeth.)
Databáze: MEDLINE